Kurve Adds Migraine Prevention Development Agreement

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Kurve Technolog has aannounced a development and collaboration agreement with Seurat Therapeutics, Inc. of Chicago, IL. The license includes fields of use for their proprietary technology to be used for migraine prevention in adults.

“Both Seurat and Kurve are proud to be a part of making an effort to address the efficacy of migraine management,” said Marc Giroux, CEO of Kurve Technology.

“When Seurat co-founders, Dr. Richard Kraig, Dr. Martin Sanders and Yuan Zhang contacted me regarding this therapy, it was a natural fit. As a company, Kurve has been interested in this area for some time and Seurat’s approach offers a real opportunity. It’s an exciting time with this agreement to be moving forward with our proprietary technology platform.”

“We are pleased to see our business model of superior technology in a device that offers brand loyalty and market strength through the base unit and replaceable cartridges be accepted by Seurat and we foresee a bright future,” said Giroux.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.